Concepedia

Jitong Lou

JL

Statistics

Publications

5

Citations

609

H-Index

5

Active since

2018

Affiliations

University of North Carolina at Chapel Hill(Current)

Xuzhou Medical College

UNC Lineberger Comprehensive Cancer Center

Eli Lilly (United States)

Jitong Lou is an author at University of North Carolina at Chapel Hill specializing in life sciences, immunology, and cancer genetics.

Publications per year

2018–2024

5

Publications

5

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

Julio Rosenstock, Juan P. Frías, Ania M. Jastreboff et al. · The Lancet · 2023 · 376 citations

Medicine, Endocrinology, Pharmacology +14

DCAF1 regulates Treg senescence via the ROS axis during immunological aging

Zengli Guo, Gang Wang, Bing Wu et al. · Journal of Clinical Investigation · 2020 · 160 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma

Xing Cheng, Jing An, Jitong Lou et al. · Nature Communications · 2024 · 30 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased Programs

Bing Wu, Song Zhang, Zengli Guo et al. · Immunity · 2018 · 23 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Rad18 mediates specific mutational signatures and shapes the genomic landscape of carcinogen-induced tumors<i>in vivo</i>

Jitong Lou, Yang Yang, Qisheng Gu et al. · NAR Cancer · 2021 · 20 citations · Full text

Medicine, Genetics, Oncology +16

1–5 of 5